Elderwood At Burlington | |
98 Starr Farm Rd, Burlington, Vermont 05408 | |
(802) 658-6717 | |
Name | Elderwood At Burlington |
---|---|
Location | 98 Starr Farm Rd, Burlington, Vermont |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 150 |
Occupancy Rate | 60.47% |
Medicare ID (CCN) | 475030 |
Legal Business Name | 98 Starr Farm Road Operating Company, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1407934334 |
Organization Name | STARR FARM PARTNERSHIP |
Doing Business As | STARR FARM NURSING CENTER |
Address | 98 Starr Farm Rd, Burlington, VT 05401 |
Phone Number | 802-658-6717 |
News Archive
In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost.
"Nothing could be more appropriate than the World Food Day focus on cooperatives this year," because "the collective power of cooperatives can enable better access to market, better returns, better access to inputs and services, and a better support network for smallholder farmers," leading to "higher returns" which allow farmers to "better provide for the nutrition, education and health of their families," Mark Bowman, managing director of SABMiller, writes in an AllAfrica.com opinion piece.
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, describes in the Lancet long-term success in four teenage girls who received vaginal organs that were engineered with their own cells.
Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.
› Verified 1 days ago
NPI Number | 1932689882 |
Organization Name | 98 STARR FARM ROAD OPERATING COMPANY, LLC |
Doing Business As | ELDERWOOD AT BURLINGTON |
Address | 98 Starr Farm Rd, Burlington, VT 05408 |
Phone Number | 802-658-6717 |
News Archive
In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost.
"Nothing could be more appropriate than the World Food Day focus on cooperatives this year," because "the collective power of cooperatives can enable better access to market, better returns, better access to inputs and services, and a better support network for smallholder farmers," leading to "higher returns" which allow farmers to "better provide for the nutrition, education and health of their families," Mark Bowman, managing director of SABMiller, writes in an AllAfrica.com opinion piece.
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, describes in the Lancet long-term success in four teenage girls who received vaginal organs that were engineered with their own cells.
Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost.
"Nothing could be more appropriate than the World Food Day focus on cooperatives this year," because "the collective power of cooperatives can enable better access to market, better returns, better access to inputs and services, and a better support network for smallholder farmers," leading to "higher returns" which allow farmers to "better provide for the nutrition, education and health of their families," Mark Bowman, managing director of SABMiller, writes in an AllAfrica.com opinion piece.
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, describes in the Lancet long-term success in four teenage girls who received vaginal organs that were engineered with their own cells.
Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $7543 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 21.14 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.05 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.43 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.02 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.28 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 14.16 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 7.87 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 61.15 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 21.88 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 47.19 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.93 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 36.5 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.49 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.98 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.81 | 95.98 |
Percentage of short-stay residents who made improvements in function | 72.4 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 57.62 | 82.93 |
News Archive
In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost.
"Nothing could be more appropriate than the World Food Day focus on cooperatives this year," because "the collective power of cooperatives can enable better access to market, better returns, better access to inputs and services, and a better support network for smallholder farmers," leading to "higher returns" which allow farmers to "better provide for the nutrition, education and health of their families," Mark Bowman, managing director of SABMiller, writes in an AllAfrica.com opinion piece.
The open enrollment period begins in one week for 2018 marketplace coverage, but many consumers are confused about what to expect. No wonder!
Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, describes in the Lancet long-term success in four teenage girls who received vaginal organs that were engineered with their own cells.
Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.
› Verified 1 days ago
Birchwood Terrace Rehab & Healthcare Location: 43 Starr Farm Rd, Burlington, Vermont 05408 Phone: (802) 863-6384 | |